trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Chromosome Inversion D007446 1 associated lipids
Thyroid Hormone Resistance Syndrome D018382 1 associated lipids
Rhabdomyosarcoma, Embryonal D018233 1 associated lipids
Gestational Trophoblastic Disease D031901 1 associated lipids
Carcinoma, Papillary, Follicular D018265 1 associated lipids
Visceral Pain D059265 1 associated lipids
Rhabdoid Tumor D018335 1 associated lipids
Lupus Vulgaris D008177 1 associated lipids
Rubinstein-Taybi Syndrome D012415 1 associated lipids
Goldenhar Syndrome D006053 1 associated lipids
Classical Lissencephalies and Subcortical Band Heterotopias D054221 1 associated lipids
Capsule Opacification D058442 1 associated lipids
Adenomyosis D062788 1 associated lipids
Neoplasm Micrometastasis D061206 1 associated lipids
Cystadenoma, Serous D018293 1 associated lipids
Intervertebral Disc Degeneration D055959 1 associated lipids
Supratentorial Neoplasms D015173 1 associated lipids
von Hippel-Lindau Disease D006623 1 associated lipids
Hypesthesia D006987 1 associated lipids
Cystadenocarcinoma, Mucinous D018282 1 associated lipids
Myopathy, Central Core D020512 1 associated lipids
Roseolovirus Infections D019349 1 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Adenocarcinoma, Papillary D000231 2 associated lipids
Inflammatory Breast Neoplasms D058922 2 associated lipids
Ganglioneuroma D005729 2 associated lipids
Fibromatosis, Aggressive D018222 2 associated lipids
Cystadenocarcinoma, Serous D018284 2 associated lipids
Rhabdomyosarcoma, Alveolar D018232 2 associated lipids
Small Cell Lung Carcinoma D055752 2 associated lipids
Uveal Neoplasms D014604 3 associated lipids
Leukemia, Promyelocytic, Acute D015473 3 associated lipids
Conjunctival Neoplasms D003230 3 associated lipids
Adenocarcinoma, Follicular D018263 3 associated lipids
Hypereosinophilic Syndrome D017681 3 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Retinal Neoplasms D019572 3 associated lipids
Progeria D011371 3 associated lipids
Mastocytoma D034801 3 associated lipids
Spinocerebellar Ataxias D020754 4 associated lipids
Nasopharyngeal Neoplasms D009303 4 associated lipids
Neuroendocrine Tumors D018358 4 associated lipids
Porcine Reproductive and Respiratory Syndrome D019318 4 associated lipids
Cicatrix, Hypertrophic D017439 4 associated lipids
Opioid-Related Disorders D009293 5 associated lipids
Osteomalacia D010018 5 associated lipids
Fragile X Syndrome D005600 5 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Polycystic Kidney, Autosomal Dominant D016891 6 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Leukemia, Myelomonocytic, Acute D015479 6 associated lipids
Cytomegalovirus Infections D003586 7 associated lipids
Genomic Instability D042822 7 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Enteritis D004751 8 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Chondrosarcoma D002813 9 associated lipids
Mast-Cell Sarcoma D012515 9 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Retinoblastoma D012175 12 associated lipids
Keloid D007627 12 associated lipids
Cat Diseases D002371 12 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Neoplasms D009369 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Radiation Injuries D011832 14 associated lipids
Brain Neoplasms D001932 15 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Carcinoma D002277 18 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Leishmaniasis D007896 19 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Translocation, Genetic D014178 20 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Medulloblastoma D008527 22 associated lipids
Hypersensitivity D006967 22 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Fibrosis D005355 23 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Breast Neoplasms D001943 24 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Nasal Polyps D009298 26 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Glioblastoma D005909 27 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Avila AM et al. Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. 2007 J. Clin. Invest. pmid:17318264
Alikhani-Koopaei R et al. Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression. 2004 J. Clin. Invest. pmid:15489962
Wong JE et al. Therapeutic strategies in gastric cancer. 2003 J. Clin. Oncol. pmid:14645406
Song YF et al. High-frequency promoter hypermethylation of the deleted in liver cancer-1 gene in multiple myeloma. 2006 J. Clin. Pathol. pmid:16489177
Vanniasinkam T et al. Trichostatin-A enhances adaptive immune responses to DNA vaccination. 2006 J. Clin. Virol. pmid:16765083
Shi YL et al. Histone deacetylases inhibitor Trichostatin A ameliorates DNFB-induced allergic contact dermatitis and reduces epidermal Langerhans cells in mice. 2012 J. Dermatol. Sci. pmid:22999682
Jo SJ et al. Valproic acid promotes human hair growth in in vitro culture model. 2013 J. Dermatol. Sci. pmid:23810771
Lee JH et al. Interactions with p300 enhance transcriptional activation by the PDZ-domain coactivator Bridge-1. 2005 J. Endocrinol. pmid:16293776
Margueron R et al. Oestrogen receptor alpha increases p21(WAF1/CIP1) gene expression and the antiproliferative activity of histone deacetylase inhibitors in human breast cancer cells. 2003 J. Endocrinol. pmid:14529564
Gunin AG et al. Effects of histone deacetylase inhibitors on estradiol-induced proliferation and hyperplasia formation in the mouse uterus. 2005 J. Endocrinol. pmid:15930180
Korkmaz CG et al. Potentiation of androgen receptor transcriptional activity by inhibition of histone deacetylation--rescue of transcriptionally compromised mutants. 2004 J. Endocrinol. pmid:15350180
Sponziello M et al. Regulation of sodium/iodide symporter and lactoperoxidase expression in four human breast cancer cell lines. 2010 J. Endocrinol. Invest. pmid:19794300
Zhao Y et al. Lifespan extension and elevated hsp gene expression in Drosophila caused by histone deacetylase inhibitors. 2005 J. Exp. Biol. pmid:15695762
Jiang Y et al. Homocysteine-induced extracellular superoxide dismutase and its epigenetic mechanisms in monocytes. 2008 J. Exp. Biol. pmid:18310117
Yang QC et al. Inhibition of hypoxia-induced angiogenesis by trichostatin A via suppression of HIF-1a activity in human osteosarcoma. 2006 J. Exp. Clin. Cancer Res. pmid:17310851
Liu Y et al. DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac. 2016 J. Exp. Clin. Cancer Res. pmid:27461117
Cao W et al. Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling. 2008 J. Exp. Med. pmid:18504304
Cosio BG et al. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. 2004 J. Exp. Med. pmid:15337792
Durum SK et al. Interleukin 7 receptor control of T cell receptor gamma gene rearrangement: role of receptor-associated chains and locus accessibility. 1998 J. Exp. Med. pmid:9858510
Izawa M et al. Inhibition of histone deacetylase causes reduction of appressorium formation in the rice blast fungus Magnaporthe oryzae. 2009 J. Gen. Appl. Microbiol. pmid:20118613
Wolf G et al. Epigenetic marking and repression of porcine endogenous retroviruses. 2013 J. Gen. Virol. pmid:23324470
Park JJ et al. Functional interaction of the human cytomegalovirus IE2 protein with histone deacetylase 2 in infected human fibroblasts. 2007 J. Gen. Virol. pmid:18024889
Hummel M et al. Transcriptional reactivation of murine cytomegalovirus ie gene expression by 5-aza-2'-deoxycytidine and trichostatin A in latently infected cells despite lack of methylation of the major immediate-early promoter. 2007 J. Gen. Virol. pmid:17374752
Hatama S et al. Isolation and sequencing of infectious clones of feline foamy virus and a human/feline foamy virus Env chimera. 2001 J. Gen. Virol. pmid:11714976
Nemajerová A et al. Trichostatin A suppresses transformation by the v-myb oncogene in BM2 cells. 2003 J. Hematother. Stem Cell Res. pmid:12804181
Marquardt JU et al. Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer. 2015 J. Hepatol. pmid:25937435
Rombouts K et al. Actin filament formation, reorganization and migration are impaired in hepatic stellate cells under influence of trichostatin A, a histone deacetylase inhibitor. 2002 J. Hepatol. pmid:12445420
Herold C et al. The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells. 2002 J. Hepatol. pmid:11830335
Papeleu P et al. Trichostatin A induces differential cell cycle arrests but does not induce apoptosis in primary cultures of mitogen-stimulated rat hepatocytes. 2003 J. Hepatol. pmid:12927923
Zhang C et al. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications. 2010 J. Hepatol. pmid:20675009
Chiba T et al. Identification of genes up-regulated by histone deacetylase inhibition with cDNA microarray and exploration of epigenetic alterations on hepatoma cells. 2004 J. Hepatol. pmid:15336447
Huang H et al. Expression of P53, P21 in human lung adenocarcinoma A549 cell strains under hypoxia conditions and the effect of TSA on their expression. 2003 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:15015635
Li C et al. Effect and comparison of sodium butyrate and trichostatin A on the proliferation/differentiation of K562. 2003 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:14526425
He J et al. Effects of trichostatin A on HDAC8 expression, proliferation and cell cycle of Molt-4 cells. 2006 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:17219959
Liu H et al. Trichostatin A regulates hGCN5 expression and cell cycle on Daudi cells in vitro. 2006 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:17219960
Sun C et al. Anticancer activities of trichostatin A on maligant lymphoid cells. 2006 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:17219961
Hong Z et al. Microarray study of mechanism of trichostatin a inducing apoptosis of Molt-4 cells. 2009 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:19662360
Li X et al. Regulation of histone acetylation and apoptosis by trichostatin in HL-60 cells. 2004 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:15791844
Li C et al. Induction of myelogenous leukemia cells with histone deacetylase inhibitors through down-regulating the Daxx protein expression. 2009 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:19821084
Mataki H et al. Downregulation of the microRNA-1/133a cluster enhances cancer cell migration and invasion in lung-squamous cell carcinoma via regulation of Coronin1C. 2015 J. Hum. Genet. pmid:25518741
Xu S et al. Abrogation of DUSP6 by hypermethylation in human pancreatic cancer. 2005 J. Hum. Genet. pmid:15824892
Yoshioka H et al. A novel in vitro system for analyzing parental allele-specific histone acetylation in genomic imprinting. 2001 J. Hum. Genet. pmid:11721881
Lu L et al. Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells. 2010 J. Immunol. pmid:20304828
Lee KY et al. NF-kappaB and activator protein 1 response elements and the role of histone modifications in IL-1beta-induced TGF-beta1 gene transcription. 2006 J. Immunol. pmid:16365456
Bai Y et al. Protein acetylation regulates both PU.1 transactivation and Ig kappa 3' enhancer activity. 2005 J. Immunol. pmid:16210620
Gao B et al. Inhibition of histone deacetylase activity suppresses IFN-γ induction of tripartite motif 22 via CHIP-mediated proteasomal degradation of IRF-1. 2013 J. Immunol. pmid:23729439
Grabiec AM et al. Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue. 2010 J. Immunol. pmid:20100935
Bachl J et al. Increased transcription levels induce higher mutation rates in a hypermutating cell line. 2001 J. Immunol. pmid:11290786
Gays F et al. The mouse tumor cell lines EL4 and RMA display mosaic expression of NK-related and certain other surface molecules and appear to have a common origin. 2000 J. Immunol. pmid:10799866
Maës J et al. Chromatin remodeling at the Ig loci prior to V(D)J recombination. 2001 J. Immunol. pmid:11441093
Magner WJ et al. Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors. 2000 J. Immunol. pmid:11120829
Uhlenbrock F et al. The NKG2D ligand ULBP2 is specifically regulated through an invariant chain-dependent endosomal pathway. 2014 J. Immunol. pmid:25024379
Thomas RM et al. Regulation of mouse mammary tumor virus env transcriptional activator initiated mammary tumor virus superantigen transcripts in lymphomas of SJL/J mice: role of Ikaros, demethylation, and chromatin structural change in the transcriptional activation of mammary tumor virus superantigen. 2003 J. Immunol. pmid:12496403
Serrat N et al. The response of secondary genes to lipopolysaccharides in macrophages depends on histone deacetylase and phosphorylation of C/EBPβ. 2014 J. Immunol. pmid:24307736
Sebastián C et al. Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells. 2008 J. Immunol. pmid:18424709
Ishiguro K et al. Cutting edge: tubulin α functions as an adaptor in NFAT-importin β interaction. 2011 J. Immunol. pmid:21278340
Northrop JK et al. Cutting edge: chromatin remodeling as a molecular basis for the enhanced functionality of memory CD8 T cells. 2008 J. Immunol. pmid:18606637
Schmeck B et al. Histone acetylation and flagellin are essential for Legionella pneumophila-induced cytokine expression. 2008 J. Immunol. pmid:18606645
Zabel MD et al. Lymphoid transcription of the murine CD21 gene is positively regulated by histone acetylation. 1999 J. Immunol. pmid:10453011
Zhang Y et al. Pro-IL-16 recruits histone deacetylase 3 to the Skp2 core promoter through interaction with transcription factor GABP. 2008 J. Immunol. pmid:18097041
Laribee RN and Klemsz MJ Loss of PU.1 expression following inhibition of histone deacetylases. 2001 J. Immunol. pmid:11673528
Nakazawa Y et al. Evaluation of long-term transgene expression in piggyBac-modified human T lymphocytes. 2013 J. Immunother. pmid:23211626
Russell SB et al. Epigenetically altered wound healing in keloid fibroblasts. 2010 J. Invest. Dermatol. pmid:20555348
Tigges J et al. Aryl hydrocarbon receptor repressor (AhRR) function revisited: repression of CYP1 activity in human skin fibroblasts is not related to AhRR expression. 2013 J. Invest. Dermatol. pmid:22951721
Markova NG et al. Inhibition of histone deacetylation promotes abnormal epidermal differentiation and specifically suppresses the expression of the late differentiation marker profilaggrin. 2007 J. Invest. Dermatol. pmid:17195011
Johnson JL et al. The desmosomal protein desmoglein 1 aids recovery of epidermal differentiation after acute UV light exposure. 2014 J. Invest. Dermatol. pmid:24594668
Schauber J et al. Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-dihydroxyvitamin D3. 2008 J. Invest. Dermatol. pmid:17943182
Sung TY et al. Innovative in vitro chemo-hormonal drug therapy for refractory thyroid carcinomas. 2012 J. Korean Med. Sci. pmid:22787366
Jung N et al. Pharmacological unmasking microarray approach-based discovery of novel DNA methylation markers for hepatocellular carcinoma. 2012 J. Korean Med. Sci. pmid:22690089
Tran HT et al. Improved therapeutic effect against leukemia by a combination of the histone methyltransferase inhibitor chaetocin and the histone deacetylase inhibitor trichostatin A. 2013 J. Korean Med. Sci. pmid:23400519
Phelan MW et al. Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells. 1998 J. Lab. Clin. Med. pmid:9851743
Reddy P Editorial: HDAC inhibition begets more MDSCs. 2012 J. Leukoc. Biol. pmid:22547132
Rosborough BR et al. Histone deacetylase inhibition facilitates GM-CSF-mediated expansion of myeloid-derived suppressor cells in vitro and in vivo. 2012 J. Leukoc. Biol. pmid:22028329
Rossi LE et al. Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression. 2012 J. Leukoc. Biol. pmid:22124136
Halili MA et al. Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS. 2010 J. Leukoc. Biol. pmid:20200406
Claus R et al. Inhibitors of DNA methylation and histone deacetylation independently relieve AML1/ETO-mediated lysozyme repression. 2006 J. Leukoc. Biol. pmid:17000900
Bosisio D et al. Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo. 2008 J. Leukoc. Biol. pmid:18780875
Moldenhauer A et al. Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins. 2004 J. Leukoc. Biol. pmid:15197237
Nunes MJ et al. Okadaic acid inhibits the trichostatin A-mediated increase of human CYP46A1 neuronal expression in a ERK1/2-Sp3-dependent pathway. 2012 J. Lipid Res. pmid:22693257
Clarke CJ et al. ATRA transcriptionally induces nSMase2 through CBP/p300-mediated histone acetylation. 2016 J. Lipid Res. pmid:27013100
Olsen CA and Ghadiri MR Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides. 2009 J. Med. Chem. pmid:19705846
Trapp J et al. Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition. 2006 J. Med. Chem. pmid:17149860
Baud MG et al. Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets. 2012 J. Med. Chem. pmid:22280363
Remiszewski SW et al. N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824). 2003 J. Med. Chem. pmid:14521422
Jung M et al. Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation. 1999 J. Med. Chem. pmid:10579829
He R et al. Synthesis and biological evaluation of triazol-4-ylphenyl-bearing histone deacetylase inhibitors as anticancer agents. 2010 J. Med. Chem. pmid:20055418
Auzzas L et al. Non-natural macrocyclic inhibitors of histone deacetylases: design, synthesis, and activity. 2010 J. Med. Chem. pmid:21073160
Huber K et al. Novel 3-arylideneindolin-2-ones as inhibitors of NAD+ -dependent histone deacetylases (sirtuins). 2010 J. Med. Chem. pmid:20030343
Wittich S et al. Structure-activity relationships on phenylalanine-containing inhibitors of histone deacetylase: in vitro enzyme inhibition, induction of differentiation, and inhibition of proliferation in Friend leukemic cells. 2002 J. Med. Chem. pmid:12109913
Lu Q et al. Structure-based optimization of phenylbutyrate-derived histone deacetylase inhibitors. 2005 J. Med. Chem. pmid:16107152
Heltweg B et al. Subtype selective substrates for histone deacetylases. 2004 J. Med. Chem. pmid:15456267
Paris M et al. Histone deacetylase inhibitors: from bench to clinic. 2008 J. Med. Chem. pmid:18247554
Xiao J et al. Discovery, synthesis, and biological evaluation of novel SMN protein modulators. 2011 J. Med. Chem. pmid:21819082
Mai A et al. Binding mode analysis of 3-(4-benzoyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamide: a new synthetic histone deacetylase inhibitor inducing histone hyperacetylation, growth inhibition, and terminal cell differentiation. 2002 J. Med. Chem. pmid:11960489
Mai A et al. Synthesis and biological properties of novel, uracil-containing histone deacetylase inhibitors. 2006 J. Med. Chem. pmid:17004718
Chen Y et al. A series of potent and selective, triazolylphenyl-based histone deacetylases inhibitors with activity against pancreatic cancer cells and Plasmodium falciparum. 2008 J. Med. Chem. pmid:18494463
Miller TA et al. Histone deacetylase inhibitors. 2003 J. Med. Chem. pmid:14613312
Itoh Y et al. Design, synthesis, structure--selectivity relationship, and effect on human cancer cells of a novel series of histone deacetylase 6-selective inhibitors. 2007 J. Med. Chem. pmid:17929798
Neelarapu R et al. Design, synthesis, docking, and biological evaluation of novel diazide-containing isoxazole- and pyrazole-based histone deacetylase probes. 2011 J. Med. Chem. pmid:21548582
Suzuki T et al. Highly potent and selective histone deacetylase 6 inhibitors designed based on a small-molecular substrate. 2006 J. Med. Chem. pmid:16884291